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Abstract
The myocardium of the heart is composed of multiple highly specialized myocardial lineages,
including those of the ventricular and atrial myocardium, and the specialized conduction system.
Specification and maturation of each of these lineages during heart development is a highly
ordered, ongoing process involving multiple signaling pathways and their intersection with
transcriptional regulatory networks. Here, we attempt to summarize and compare much of what
we know about specification and maturation of myocardial lineages from studies in several
different vertebrate model systems. To date, most research has focused on early specification, and
while there is still more to learn, less is known about factors that promote subsequent maturation
of myocardial lineages required to build the functioning adult heart.
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Introduction
The cardiomyocyte is the fundamental work unit of the heart. Although cardiomyocyte cell
fate is a developmental endpoint, a diversity of cardiomyocyte subtypes exist within the
heart. These include the outflow tract, right ventricle, left ventricle, atria, myocardial sleeves
of cranial and caudal great vessels, and specialized conduction system tissue, including the
SA node, AV node, and His-Purkinje tracts. The recent interest in production of
cardiomyocytes for repair of the diseased heart has heightened the importance of a detailed
understanding of cardiac lineage specification and differentiation.
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To provide context for understanding the locations, contributions and patterning of
progenitor cells, this review begins with a brief overview of the “basics” of heart
development in mouse, chick, frog and fish, and then discusses aspects of myocardial
development under the two broad headings of “specification”, dealing with patterning and
growth of undifferentiated myocyte progenitors, and “differentiation”, dealing with
subspecialization and growth of distinct myocyte lineages following differentiation.
Buckingham and Vincent have recently published an excellent review of similar information
and we refer the reader to the figures in that review for signaling and transcriptional network
diagrams.1 A glossary of terms used in this review has been supplied as an online
supplement.
I. Basic Mouse and Chick Heart Development (Figure 1, Table 1)
Before gastrulation, both chick and mouse embryos are composed of two cell layers, epiblast
and hypoblast (chick) or primitive endoderm (mouse). The epiblast contributes all
embryonic and some extra-embryonic tissues. Regional expression of genes and cell fate
mapping suggest that embryonic anterior-posterior and left-right axes are established prior to
gastrulation.2 Fate mapping experiments have demonstrated that heart precursors are located
in the posterior/caudal epiblast and will be adjacent to the anterior/cranial two-thirds of the
primitive streak when it forms, making heart progenitors among the earliest embryonic cells
to gastrulate.3, 4
Formation of the three germ layers, ectoderm, mesoderm, and endoderm results from
ingression of epiblast cells through the primitive streak at gastrulation.5 Early in gastrulation
(embryonic day (E) 6.5, mouse); Hamilton Hamburger Stage 3(HH, chick), the primitive
streak elongates cranially until mid-gastrulation, at which time most cardiac progenitors
ingress.6, 7 Progenitor cells of pharyngeal and foregut endoderm are localized next to
cardiogenic mesoderm progenitors in the epiblast, migrating through the early to mid-
primitive streak to integrate with extraembryonic endoderm, progressively displacing the
latter, coincident with the migration of the early cardiogenic mesoderm.8 Following
ingression, cardiogenic mesoderm moves anterolaterally as a sheet of cells, and by late
primitive streak stages is localized as identifiable bilateral “fields” in anterior lateral plate
mesoderm (chick) or as a cardiac crescent (mouse).6, 9
During gastrulation, the craniocaudal arrangement of progenitors is shifted 90°: the most
cranial cells in the epiblast become the most medial in the mesoderm and the most caudal
cells in the epiblast become the most lateral in the mesoderm.9, 10 The chick embryo
undergoes an extended period in which the bilateral heart fields remain as progenitors and
do not show signs of differentiation until they move to the midline.11, 12 In contrast, in the
mouse the cardiogenic fields move quickly to the midline, anterior to the forming neural
plate, where they join to form a cardiac crescent of differentiating cardiomyocytes. In both
chick and mouse, embryo folding to form the foregut pocket carries the cranial cells in the
cardiogenic fields ventrocaudally resulting in an inversion of cardiogenic mesoderm.10 The
cranial-lateral borders of the heart fields meet at E8.0 (HH9) to form the ventral seam of the
early heart “tube” which is at this stage more accurately described as a myocardial trough
open dorsally toward the ventral pharynx.10, 13 14
It is not until the tube closes dorsally and its attachment to the ventral pharynx, called the
primary dorsal mesocardium, breaks down that an actual tube is formed. Partial rupture of
the dorsal mesocardium allows the tube to be detached from the ventral pharynx except at its
venous (caudal, inflow) and arterial (cranial, outflow) poles.15 The early myocardial tube
comprises primarily cells destined to be the left ventricle with a little right ventricle and
atrioventricular (AV) canal represented. The myocardium that will form the majority of the
right ventricle, conus and truncus are all added via the arterial pole, while the AV canal,
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atria and atrial septum are added to the venous pole.10 Heart contractions can be seen as
early as formation of the trough (E8.25, HH10) although anterograde circulation does not
begin until after the tube has formed and begins to loop.16, 17
The heart tube loops to the right (E8.5, HH11), coincident with disappearance of the dorsal
mesocardium. Initial looping is intrinsic to the myocardium followed by forces generated in
the dorsal mesocardium just before it disappears.18-20 Much of the lengthening of the tube
is due to addition of newly differentiated myocardium at the arterial and venous poles. With
progressive growth of the tube and specification of the chambers, the atria, initially located
caudal to the ventricles, become displaced cranial to the ventricles.
In the chick, myocardial progenitors proliferate at a very high rate with a cycle time of about
5.2 hrs.21 However, as soon as myocardial differentiation begins, the cells cease cycling for
an extended period. Presumably, this allows differentiation and onset of function. Growth of
the tubular heart ensues primarily from progressive addition of cells from the remaining
progenitor pool.21 Retrospective clonal lineage analysis recognizes first and second lineages
roughly corresponding to the first and second heart fields, based on their timing of
differentiation and entry into the heart.22 The cells of the first heart field are the first to
differentiate, and contribute to the left ventricle, AV canal and atria. The second heart field
constitutes a highly proliferative progenitor population that contributes progressively to the
remainder of the heart.21 These two populations of cells can be identified molecularly by
expression of differentiation versus specification markers but since the process is
progressive, there is not a definitive morphological boundary between them.
Two additional named subpopulations of the second heart field were identified using
different techniques. Gene trapping showed an FGF10-expressing subpopulation of
myocardium that contributed to the right ventricle and outflow tract. This subpopulation was
called anterior heart field.23 A second subpopulation was identified by cell tracing
techniques from the ventral splanchnic pharyngeal mesoderm that contributed myocardium
and smooth muscle to the definitive arterial pole. This subpopulation was called secondary
heart field.24, 25 Both subpopulations are second heart field progenitors. In addition, other
subpopulations have been identified recently that contribute to the inflow pole of the heart
including some of the atrial myocardial wall and the atrial septum via the dorsal
mesenchymal protrusion (spina vestibulae) and the myocardial sleeves on the sinus venosus
and pulmonary veins. Because all these subpopulations originate from the second heart field
we will refer to them primarily by what they contribute to the heart and not use the more
confusing subpopulation designations.
The progenitor population that contributes to the definitive arterial pole, comprised of
truncal myocardium and smooth muscle that will form the tunica media at the base of the
great arterial trunks, is located in the ventral pharynx behind the outflow tract.24-26 The
myocardial cells are added in two spirals that become the myocardial underpinning of the
aorta and pulmonary trunk.27, 28 The smooth muscle that forms the base of the arterial
trunks is added after the myocardium and does not spiral.24 Ablation of chick arterial pole
progenitors on the right leads to overriding aorta and pulmonary stenosis or atresia, which
are key components of tetralogy of Fallot.27 Manipulations that interfere with proliferation
of arterial pole progenitors cause the same phenotype 29, 30
Although initial differentiation of myocardial cells is accompanied by cessation of
proliferation, chamber myocardial cells reinitiate a proliferative phase at about HH14 after
anterograde circulation is established. This proliferation accounts for “ballooning” of the
ventricles and establishment of the trabeculae.31, 32 Myocardium of the outflow tract and
AV canal is relatively non-proliferative. The early trabecular ventricular myocardium of the
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embryonic heart undergoes growth and compaction to result in the final form of the
ventricular myocardial wall.
At approximately E9.5 (HH15), the outflow tract and AV cushions form, which initially
block retrograde blood flow and later contribute to septation of these regions. Formation of
the cushions is succeeded by growth of the muscular ventricular septum and formation of
the primary atrial septum by ingrowth of myocardializing mesoderm in the dorsal
mesocardial protrusion from progenitors located dorsal to the common atrium.33 At E10
(HH24), cardiac neural crest cells migrate into the distal outflow cushions where they form
the aorticopulmonary septation complex of condensed mesenchyme.34, 35 The neural crest-
derived mesenchyme orchestrates septation of the aorta and pulmonary trunk and the distal
outflow tract. Closure of the proximal outflow tract is by conal and AV cushion tissue after
the distal septum has formed. Septation into four chambers is completed by E14.5 (HH34).
Remodeling of outflow tract and AV cushions to form valves is an ongoing progress, which
continues postnatally.36
Cells from the proepicardium give rise to the epicardial epithelium covering the heart. The
proepicardium arises from septum transversum mesenchyme near the venous pole of the
heart and is evident from approximately E9.5 (HH16) to E10.5.37, 38 Once formed the
epicardial cells contribute a number of cell types to the heart, including smooth muscle cells
of the coronary vessels, cardiac fibroblasts, and potentially, a subset of cardiomyocytes,
although the latter is controversial.39-41
II. Frog and Fish Heart Development (Figure 2, Table 1)
The early stages of frog and fish heart formation bear a strong resemblance to the early
stages of mouse and chick heart development, despite the differences in embryonic anatomy
between species. In this section, we highlight major stages of Xenopus and zebrafish heart
development that correspond to the phases of mouse and chick development described
above (Table 1). This correspondence guides our understanding of the conserved elements
of the genetic pathways that regulate myocardial progenitor specification and differentiation.
Classical fate mapping studies in Xenopus demonstrated that three hours after fertilization, a
pair of blastomeres in the dorsal equatorial zone is fated to give rise to the adult heart
(Figure 2a).42, 43 As with all mesolecithal embryos, Xenopus cells do not undergo extensive
cell mixing during the early stages of embryogenesis; thus, by the onset of gastrulation
(stage 10), the descendants of these two blastomeres give rise to a coherent bilateral
population of cells in direct contact with the organizer and underlying endoderm. Fate
mapping studies in the zebrafish early blastula found myocardial and endocardial
progenitors at the ventrolateral margin of the embryo.44, 45 The distribution of progenitors
at the embryonic margin shifts slightly over time, such that the myocardial progenitors are
located in bilateral marginal zones at the onset of zebrafish gastrulation (Figure 2d).46
Following gastrulation, the myocardial progenitor population coalesces into distinct bilateral
positions within the anterior lateral plate mesoderm (Figure 2e).47
Myocardial differentiation and heart tube formation begin contemporaneously in both frog
and fish. In Xenopus, as shown by DiI labeling and single cell PCR, the heart field is
comprised of an amalgamation of progenitors that include cells that will give rise to either
the future atrium or ventricle. Just prior to fusion, the fields uniformly initiate expression of
the first markers of cardiomyocyte differentiation, including troponin T, MLC2a and MHCα
(stage 26/27)(Figure 2b).48, 49 As in chick, a marked decrease in the cardiac mitotic index
accompanies the formation of myofibrils and the expression of markers of terminal
cardiomyocyte differentiation.50, 51 However, differentiation of cardiomyocytes is not
directly linked to cell cycle withdrawal since blocking the cell cycle from early stages (prior
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to stage 24) has no effect on timing of cardiomyocyte differentiation in whole embryos or in
cardiac explants.51, 52 By early tadpole stages (stage 29/30), the midline heart field begins
to round up at its lateral edges to form a myocardial trough that eventually covers the
endocardial tube. The trough then gradually closes in a caudal-to-cranial fashion over the
dorsal surface of the endocardium such that by mid-tadpole stage (stage 32), the heart
comprises a bi-layered linear heart tube.53, 54
In zebrafish, myocardial differentiation initiates within the bilateral heart fields by 16 hours
post-fertilization (hpf), as evidenced by the expression of genes encoding sarcomere
components, such as cardiac myosin light chain 2.55 Time-lapse studies have tracked the
migration of these bilateral sheets of cardiomyocytes as they travel toward the midline to
create a ring of cells, referred to as the cardiac cone, through a process termed cardiac fusion
(Figure 2f).56 The myocardial cone engulfs a centrally located sheet of endocardial
precursors, and together these structures gradually elongate to transform from a shallow
conical structure into a two-layered primitive heart tube.57, 58
The frog and fish heart tubes transform into looped, multi-chambered organs through a
combination of morphogenesis and growth. By stage 35, the Xenopus heart begins to loop;
shortly thereafter, its chambers begin to adopt distinct morphological features, including
thickening and trabeculation of the ventricular myocardium. In the frog at stage 45/46,
septation of the atrium completes formation of the mature three-chambered heart.48, 49
Although there is a continual decrease in hyperplastic growth during these stages, the
number of cardiomyocytes continues to increase, implying that new cardiomyocytes are
added through the recruitment of cells from extra-cardiac sources.49-51 Indeed, recent fate
mapping studies in Xenopus support the existence of a second heart field that arises from a
pool of cardiac progenitors coexpressing Isl-1 and Nkx2.5. A subset these cells later
downregulate Isl-1 while maintaining Nkx2.5 expression thus, establishing the first and
second heart field. In addition to Isl1, the Xenopus secondary heart field also expresses
many markers associated with the second field in mouse and chick including Tbx1, Flk1 and
Islet1 (Figure 2c).59, 60 However, the relative contribution of the second heart field to the
poles of the Xenopus heart remains to be established.
Similarly, the zebrafish heart tube develops into a two-chambered organ between 24 and 48
hpf through looping, constriction of the AV canal, and the distinctive bulging that creates
the characteristic curvatures of the ventricle and atrium.61 The number of cardiomyocytes
increases during this transition although little proliferation occurs. The accretion of
cardiomyocytes is a consequence of recruitment of new, late-differentiating cardiomyocytes
to both the arterial and venous poles of the heart tube.62
Altogether, the similarities between the early steps of heart formation in mouse, chick, frog,
and fish support the validity of all of these model organisms for investigation of the
molecular mechanisms driving cardiac progenitor specification and differentiation.
III. Myocardial Specification
Regional patterning in the epiblast is likely to determine the time at which cells fated to
become myocytes undergo gastrulation. Cells fated to become cardiomyocytes are among
the first to ingress through the primitive streak.63 The ingressing cells are organized in a
colinear alignment from inflow to outflow: atrial (venous pole) progenitors are located most
caudally, while AV, left ventricular, right ventricular, and conus cardiomyocyte progenitors
located successively more cranially.4, 9, 64, 65 Transplantation of cell clusters from the
epiblast of mouse embryos demonstrated that descendents can contribute to myocardium,
endocardium, and epicardium, suggesting progenitors of these lineages are in close
proximity in the epiblast.3
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Several experiments suggest that cells within the epiblast are not yet committed to specific
lineages. Presumptive cardiac epiblast cells from mouse embryos transplanted into chick
embryo somites do not undergo cardiomyocyte differentiation, but interaction with
cardiogenic mesoderm in proximity to pharyngeal/foregut endoderm is sufficient to convert
early primitive streak epiblast cells not normally destined for the heart to a myocardial cell
fate.3,66 Ingression during gastrulation may result in restriction of lineage potency, as
ingressed cells in the anterolateral plate mesoderm of a mid-streak mouse embryo, when
transplanted to the epiblast, can undergo ingression, but do not colonize lateral plate
mesoderm.3 Consistent with this, cardiogenic mesoderm from late streak (E7.5) explants
transplanted into chick embryo somites differentiate into cardiomyocytes, suggesting that
cell fate has become restricted at this stage.66 Retroviral lineage studies in chick embryos
showed that myocardial and endocardial progenitors within early (HH3) primitive streak are
already segregated.67, 68
In summary, regional signaling in the epiblast positions presumptive cardiac lineages within
the posterior epiblast, where they undergo gastrulation from mid- to late- streak stages. The
ordered arrangement of presumptive anterior-posterior progenitors may reflect the relative
proximity of each progenitor to the node during ingression, as dictated by their original
spatial orientation to each other. Specification and restriction of myocardial cell fate is likely
to initiate during gastrulation, and also involves signaling within the cardiac crescent and
adjacent pharyngeal endoderm. The timeframe for cardiac specification appears to be
comparable in both frog and fish: in Xenopus, extirpation, explantation, and tissue
recombination studies suggest that cardiac specification begins at the onset of gastrulation,
69-71 and in zebrafish, experiments employing pharmacological antagonists suggest
myocardial specification occurs during gastrulation.72-74
a. Early Cardiac Specification—As cells ingress through the cranial primitive streak
they are exposed to signaling factors expressed in and around the node including retinoic
acid and FGFs.75, 76, 81 FGFs produced by the node can induce expression of Nkx2.5
locally77 and an ectopic node can induce ventricular myosin heavy chain (vMHC) but not
atrial myosin heavy chain (aMHC) expression. Because ventricular progenitors are closer to
the node, this suggests that ventricular cardiomyocyte identity may be established in the
primitive streak.78
The earliest identified indicator of cardiogenic mesoderm is the transcription factor Mesp1
expressed at the onset of gastrulation, E6.5-7.5.79 However Mesp1 is not specific for the
cardiogenic mesoderm, as Mesp1Cre labeled lineages broadly contribute to multiple
mesoderm-derived populations in the embryo. Mesp1 is downstream of Fgfr1 signaling, and
both Mesp1 and Mesp2 are required for mesodermal ingression during gastrulation.
Mutation of Mesp1 results in cardia bifida, and cells that are doubly mutant for Mesp1 and
Mesp2 are selectively unable to contribute to the heart, suggesting a critical role in cardiac
mesoderm specification. Mesp1 is upstream of a number of cardiac specification
transcription factors, including Nkx2.5, Islet1 and myocardin, which begin to be expressed at
the cardiac crescent stage.
After gastrulation, molecular markers begin to be useful indicators of the location of the
heart fields in cranial lateral plate mesoderm. In Xenopus, the first markers of the cardiac
lineage, including Nkx2.5, Tbx5, Tbx20, Gata4, Gata5, and Gata6, are not expressed until
neurula stage, when the heart progenitors have moved anteroventrally. However, as in other
vertebrate model systems, analysis of the cardiac lineage in Xenopus is confounded by the
fact that most of these markers are expressed in neighboring non-cardiac tissue or in only a
subset of cardiac progenitors.80 Thus, it is the combinatorial expression of these
transcription factors that marks cardiac progenitor cells.59 The situation is similar in
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zebrafish, where the same transcription factors, with the addition of Hand2, combinatorially
distinguish the locations of the heart fields.47
As cardiac progenitors move cranial-laterally during gastrulation to arrive at the cardiac
crescent, they are exposed to factors produced by endoderm, including FGFs and BMPs.81,
82 In mouse, expression of Nkx2.5 in the cardiac crescent is dependent on BMP2 signaling.
83, 84 However, in the second heart field, Nkx2.5 interacts directly with Smad to
downregulate BMP2 signaling which limits the number of cardiomyocytes that differentiate
to populate the initial heart tube.84 Signaling through the hedgehog receptor smoothened is
also required for the early phase of Nkx2.5 expression in the cardiac crescent, although not
for the later phase within the developing heart.85 In Xenopus embryos, inhibition of Wnt
signaling in endoderm is required for expression of an as yet unidentified secreted factor
required for cardiac specification.82
Key signals specifying myocardial progenitors are likely to be conserved among vertebrate
species. Indeed, studies in zebrafish have indicated the importance of the BMP, FGF, and
Nodal pathways. For example, swirl (bmp2b), acerebellar (fgf8), and one-eyed pinhead
(oep) mutants all exhibit a decreased number of cardiomyocytes preceded by decreased
expression of early markers of myocardial identity, such as nkx2.5.86, 87 Similarly, loss of
Hedgehog signaling in zebrafish smoothened mutants reduces the number of myocardial
progenitors.74 Furthermore, fate map analyses have suggested that loss of Nodal or
Hedgehog signaling leads to a loss of cardiac progenitors via cell fate change, rather than
through effects on progenitor proliferation.46, 74 Integration of BMP, FGF, Nodal, and
Hedgehog signals within the zebrafish heart field is likely to trigger commitment to a
myocardial fate.
Comparable signaling pathways may also be active in Xenopus, where signals from the
embryonic organizer and the endoderm act together to specify the cardiac lineage.69-71
Candidate molecules with either a passive or instructive role in Xenopus cardiac
specification include members of the BMP, FGF, and Wnt families. In addition, an
inhibitory role in cardiac specification has been proposed for the Notch pathway.88
However, neither activation nor inhibition of any components of these pathways has been
shown to block Xenopus heart formation in vivo. Collectively, these studies suggest that
cardiac specification in Xenopus depends on either a combination of redundant signal
transduction pathways or an as yet unidentified signaling mechanism.
In all the animal models studied, the LIM homeodomain transcription factor Islet1 marks
proliferating undifferentiated cardiogenic progenitors. Islet1 is required for proliferation and
survival of second heart field progenitors, and may be required for their migration into the
heart.89 Early expression of Islet1 is dependent on canonical Wnt signaling through beta-
catenin and on Fgf8 signaling, both of which are required for proliferation of early cardiac
progenitors.90-92 Wnt2a, 2b and 8 are expressed in appropriate regions and may serve as
ligands in the mouse.93-95 Expression of a mesodermal enhancer of Islet1 is dependent on
three conserved consensus Forkhead transcription factor binding sites.96 Islet is upstream of
expression of BMP4, BMP7, and Fgf10, and regulates expression of Shh in pharyngeal
endoderm, all of which may contribute to its role in driving proliferation. Mutants in which
Fgf8 is ablated by Mesp1Cre exhibit arterial pole defects reflecting the required function of
Fgf8 in arterial pole progenitors of the second heart field. By contrast Islet1 mutants have
both arterial and venous pole defects.97, 98 In chick explants, FGF does not appear to
enhance proliferation in outflow progenitors but is more likely to suppress myocardial
differentiation and promote smooth muscle differentiation, suggesting perhaps an earlier role
for Fgf8 in proliferation of mesodermal progenitors.99
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Several experiments suggest a pivotal role for GATA4 or GATA5 in cardiomyocyte
specification. In zebrafish embryos, ectopic expression of Gata5 is sufficient to specify non-
cardiogenic mesoderm to a cardiogenic fate100 and ectopic Gata4 can induce myocardial
differentiation of Xenopus ectodermal explants, in the absence of endoderm.101 Recent
experiments in gastrulating mouse embryos demonstrated that ectopic expression of the
chromatin remodeling factor Baf60c and GATA4 is sufficient to specify non-cardiogenic to
cardiogenic mesoderm, and the addition of Tbx5 to these two factors is sufficient to promote
cardiomyocyte differentiation.102
While some factors specify cardiogenic mesoderm, others restrict the cardiogenic field.
Retinoic acid signaling imposes the posterior limit of the early cardiac crescent. In chick
embryos, exposure to retinoic acid produces atrial expansion.103 Mutation of the retinoic
acid synthesizing enzyme retinaldehyde dehydrogenase 2 (RALDH2) in mouse results in
expansion of Islet1 and Fgf8 expression, and consequent enlargement of the heart.104, 105
Similarly, in zebrafish, mutation of raldh2 causes formation of large hearts composed of too
many cardiomyocytes.106 Fate mapping demonstrated that this myocardial surplus results
from a fate transformation that increases myocardial progenitor density within the forming
heart field.106 Intriguingly, an increased number of cardiomyocytes is also observed in
embryos lacking function of hoxb5b, a retinoic acid-responsive gene expressed within the
forelimb field, which is located just posterior to the heart field.107 Thus, it seems that
retinoic acid signaling restricts the developmental potential of the heart field at least in part
through its influences on neighboring territories of lateral mesoderm. Wnt signaling also
inhibits cardiac progenitor specification within the heart field, although it has also been
shown to have a positive influence at earlier stages.108 Additional pathways that control
endothelial and hematopoietic specification contribute to the restriction of myocardial
progenitor specification. Ectopic cardiomyocytes and enlarged hearts form in zebrafish
mutants that lack vessel and blood lineages, and fate mapping demonstrated that this
phenotype is caused by transformation of a cranial region of lateral mesoderm that normally
produces endothelial and hematopoietic progenitor cells.47 It is not yet clear how the
network of multiple inductive and repressive pathways is interwoven to produce the proper
number of myocardial progenitors.
b. Left Right Patterning—The heart exhibits left-right asymmetry, critical for a number
of aspects of cardiogenesis.57 Humans with laterality defects exhibit abnormal venous and
arterial connections of the heart. Evidence of left-right patterning in both chick and mouse
can be observed in asymmetrical expression of a number of genes at late gastrulation.109,
110 Left-sided nodal expression in perinodal tissue is correlated with left sided expression of
Nodal, Lefty, and Pitx2 in lateral mesoderm associated with cardiogenic mesoderm.111, 112
Selective contribution of left and right heart field progenitors to specific regions of the heart
is determined by complex morphogenetic movements, regulated by differential cell
proliferation and cell shape changes driven by distinct genetic programs within left and right
progenitors. We are just beginning to understand the manner in which laterality cues drive
these specific cell behaviors to shape organ morphogenesis and laterality. An interesting
example of this is demonstrated by studies in zebrafish.57 An early manifestation of
asymmetric morphogenesis in zebrafish is the leftward jogging of the heart tube, which is
dependent on asymmetric BMP signaling, with greater signaling activity on the left. BMP
signaling acts to direct the relative speed and direction of cardiomyocyte migration.
Simultaneously with the onset of jogging, myocardial cells on the right side of the cardiac
cone involute and move ventrally in a cranial and leftward direction. In this way,
cardiomyocytes derived from the right heart field form the ventral part of the cardiac tube,
while cardiomyocytes derived from the left heart field contribute to the dorsal roof of the
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tube. Perturbation of left-right signaling pathways affects the orientation of tissue involution
and heart tube jogging.
Similar imposition of left-right patterning to dorsal and ventral domains within the heart
occurs in other model organisms. Left and right heart field progenitors meet in the ventral
midline. In the frog, cells that express a newly described gene called Castor populate the
midline. This population is important for fusion of the two sides in Xenopus and may be
important in maintaining a boundary between derivatives of the left and right heart field in
the left ventricle.113 In chick and mouse, once the dorsal seam has closed and the dorsal
mesocardium regressed, the looping tube rotates 90° to the right. This brings the left heart
field derived myocardium on the left ventricle to the ventral surface of the looped tube while
right heart field derived myocardium is turned dorsally.10 Even though the ventricles are
from both heart fields the cells from left and right do not mix at the greater and lesser
curvatures.10 It is not known if this arrangement is maintained by cells that are added to the
tube to form the right ventricle and outflow tract myocardium.
Expression of Pitx2c in the heart delineates structures derived from left lateral plate
mesoderm, which include the left AV canal, the inner curvature, the ventral part of the
interventricular ring, the ventral portion of the right and left ventricles, and the left atrial
appendage.114-116 Available data suggest that left and right atria are derived from left and
right heart fields, respectively.10, 117 DiI labeling of the cardiogenic fields demonstrated that
progenitor cells in the right or left caudal second heart field contribute to the right or left
atrium, respectively.
Some atrial myocytes are contributed from the first heart field but the atria and atrial septum
are substantially supplemented by addition of cells from the second heart field.33, 118, 119
The derivation of atrial cardiomyocytes is very diverse and encompasses at least four
different lineages including atrioventricular myocardium which shifts into the atrium during
later development, atrial myocardium derived from the first heart field, myocardium
incorporated from the sinus venosus and pulmonary veins both of which are derived from
second heart field.115, 120
Explant experiments with transgenic mouse embryos, in which a transgene marks the right
atrium, show that atrial progenitor cells acquire right-left identity between the 4- and 6-
somite stages, at the time when Pitx2c is first expressed. Pitx2 functions in second heart
field myocardium to repress right atrial identity and proliferation of cells around the left
sinus venosus.121 Myocardial specific ablation of Pitx2 results in abnormal persistence of
BMP10 expression in fetal left atrium, resulting in an enlarged left atrium exhibiting right
atrial morphology,122 consistent with right atrial isomerism previously observed in Pitx2
global null embryos.116 It is interesting to speculate that Pitx2 may also restrict growth of
ventricular cells derived from progenitors that received left-sided cues earlier in
development.
Shh is necessary for the production of asymmetry in the developing embryo. Fate mapping
studies with an inducible Gli1-CreERT2 demonstrated that hedgehog-receiving progenitors
migrate from the second heart field to populate the right-heart derived subpulmonary
myocardium.119 Shh null embryos exhibit bilateral expression of Pitx2c at arterial and
venous poles of the heart, suggesting that Shh signaling normally suppresses Pitx2c
expression on the right.123 Consistent with this, Shh mutants also exhibit left atrial
isomerism.
Consistent with left-right information being important for normal patterning of the outflow
tract, Pitx2 is upstream of a genetic cascade, including Wnt11 and TGFbeta2, which is
required for correct alignment of the great arteries with their respective ventricles.124 Pitx2
Evans et al. Page 9













interacts with beta-catenin to activate expression of Wnt11, which then acts through a non-
canonical Wnt signaling pathway to activate transcription of TGFbeta2. Vangl2, a
component of the non-canonical planar cell polarity pathway (PCP), is also required. Loop-
tail (Lp) mice, which have mutations in Vangl2, exhibit double outlet right ventricle and
aortic arch defects.125 As with Wnt11 and TGFbeta2, Vangl2 is required for the polarization
and movement of myocardializing cells into the outflow tract cushions, and RhoA and
ROCK1 are downstream mediators of the PCP signaling pathway in the developing outflow
tract.125
Tbx1 is co-expressed with Pitx2 in second heart field cells, and Pitx2 expression is
downregulated in Tbx1 mutants, suggesting a role for Tbx1 in asymmetric cardiac
morphogenesis even though Tbx1 expression is not asymmetric.126 Asymmetric expression
of Pitx2 is regulated by a Tbx1-Nkx2.5 binding enhancer. Semaphorin3C-expressing
subpulmonary myocardium is reduced and malpositioned in Tbx1 mutant hearts, consistent
with perturbation of left-right patterning.127
c. Craniocaudal Patterning—Although some of the cues involved in craniocaudal
patterning during myocardial specification have been elucidated, we know relatively little
mechanistically as to how craniocaudal patterning is integrated by developing myocardial
cells. A key regulator of craniocaudal patterning in the embryo generally, and for
myocardial cells specifically is retinoic acid. As discussed above, at early stages of cardiac
specification, retinoic acid signaling restricts the heart field. At later stages, a posterior to
anterior gradient of retinoic acid signaling is important for normal patterning of both
posterior and anterior segments of the heart.
Tbx5 expression is downstream of retinoic acid signaling, and is selectively expressed
within the left ventricle and atria. Higher levels of expression of Tbx5 in atria than in left
ventricle suggest that levels of Tbx5 reflect a retinoic acid gradient important for chamber
specialization.128, 129 Ectopic expression of Tbx5 utilizing a ventricular specific promoter
results in ectopic expression of atrial genes. Tbx5 may also define a boundary between right
and left ventricles, which is important for placement of the ventricular septum.130, 131
At the arterial pole of the heart, Crkl1 and Tbx1 positively regulate expression of retinoic
acid metabolizing enzymes, and negatively regulate RALDH2, reducing local concentrations
of retinoic acid in second heart field progenitors that will contribute to anterior segments of
the heart.132 Increased retinoic acid in Crkl1 and Tbx1 mutants affects pharyngeal
segmentation and patterning along the craniocaudal axis.132, 133 In turn, retinoic acid
represses Tbx1 expression in second heart field progenitors that will contribute to posterior
segments of the heart. It is interesting to note that Tbx1 appears at the intersection between
craniocaudal and left-right patterning.
IV. Cardiomyocyte Differentiation
Transitioning from proliferative progenitors to differentiated cardiomyocytes requires both
downregulation of expansion pathways and upregulation of differentiation pathways.
Several pathways that promote proliferation of cardiac progenitors also actively prevent
differentiation, likely by inhibition of pathways required for differentiation.
BMP signaling is required for cardiomyocyte differentiation. Expression of a dominant
negative ALK3 receptor in Xenopus embryos prevented expression of differentiation
markers in cardiogenic mesoderm, and BMP signaling is required for maintenance of Tbx20
expression.134, 135,136, 137
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Nkx2.5 represses BMP2 activated Smad1 signaling to inhibit differentiation.84 In addition to
positively regulating second heart field proliferation, Tbx1 negatively regulates
differentiation in the caudal pharyngeal region by inhibition of BMP signaling.138 Tbx1
binds Smad1 and suppresses BMP4/Smad1 signaling, and expression of Tbx1 in transgenic
mice generates phenotypes similar to those associated with loss of a BMP receptor. In Tbx1
null mutants, premature differentiation occurs within second heart field progenitors.138
Islet1, Nkx2.6, and Hod are downregulated in Tbx1 mutants, while myocardial
differentiation genes including Raldh2, Gata4, Tbx5, and a subset of muscle contractile
genes are ectopically expressed. Tbx20 is a positive effector of differentiation downstream
of BMP signaling within the heart, and also represses expression of Islet1 as progenitors
enter the heart.134, 139
Genetic analysis and protein depletion studies demonstrate that embryos lacking Tbx20
show a progressive loss of cardiomyocytes, a failure of the heart to undergo looping and
chamber formation, as well as defects in cardiomyocyte maturation.140-143 Despite the early
cardiac expression of Tbx20 in vertebrate development and the associated downregulation of
early heart markers such as Nkx2.5 and Tbx5, TBX20 depleted embryos still form a primary
heart tube which appears to be correctly patterned along the anterior-posterior axis, since
polarized expression of numerous cardiac molecular markers, including a-MyHC, b-MyHC,
Tbx5, and Gata4 are unaltered in Tbx20 mutants. Instead, the cardiac abnormalities in
Tbx20-depleted and mutant embryos appear to be the outcome of a fundamental requirement
for Tbx20 in proliferation of cardiomyocytes as demonstrated by a dramatic decrease in the
number of terminally differentiated cardiomyocytes in Tbx20 mutants.140-143
Hedgehog signaling is required for proliferation of second heart field progenitors,29 and is
required to prevent differentiation of second heart field cells as evidenced by premature
differentiation of second heart field progenitors following ablation of the smoothened
receptor with a second heart field Cre.144 Downregulation of another pathway involved in
proliferation of second heart field progenitors, Wnt/beta catenin, is required for
differentiation of myocardial progenitors, as evidenced by lack of differentiation when beta-
catenin is constitutively activated selectively in cardiac progenitors.91-93, 145
Although beta-catenin is initially required for proliferation of undifferentiated progenitors,
beta-catenin also directly regulates expression of Wnt11, which stimulates a non-canonical
Wnt pathway to effect critical aspects of cell polarity as myocardial cells differentiate.124,
125 It is interesting to speculate that activation of non-canonical signaling through Wnt11
may in turn downregulate beta-catenin, to further promote differentiation in a feedback loop,
as there are many examples where non-canonical Wnt pathways downregulate canonical
Wnt signaling.
SRF, a MADS box transcription factor, is required to regulate sarcomeric protein genes and
excitation-contraction coupling proteins. Ablation of SRF in the Nkx2-5 expression domain
results in failure to initiate cardiac beating.146 SRF regulates expression of microRNAs
miR-1 and miR-133, which are derived from a common precursor transcript. SRF interacts
with GATA4 and Nkx2.5 to regulate cardiac genes147,148. Multiple loci encode miR-1 and
miR-133, including miR-1-1, miR-1-2, miR-133a-1, miR-133a-2, and miR133b.
MicroRNAs are evolutionarily conserved small, noncoding RNA molecules that function
posttranscriptionally to negatively mRNA translation and stability thus playing critical roles
in heart development.149, 150 In keeping with the role of SRF in promoting differentiation,
MiR-1 and MiR-133 may promote cell cycle withdrawal. Overexpression of MiR-1 under
the control of the betaMHC promoter induces premature exit from cell cycle, in part by
inhibiting translation of Hand2.147 Hand2 null mutants die at E10.5 with right ventricular
hypoplasia and decreased trabeculation in the left ventricle.151 Loss of miR-1-2 in mice,
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resulting in a 50% decrease in total miR-1, results in partial lethality between E15.5 and
birth, with ventricular septal defects and cardiac dysfunction.152 Loss of miR-133a-1 and
miR-133a-2 results in excessive cardiac proliferation, partial lethality and ventricular septal
defects, similar to miR-1-2 mutants.153
A hypoxia driven pathway stimulates myofibrillogenesis. Ablation of Hypoxia-Inducible-
Factor (HIF) 1 alpha in differentiating myocytes results in lack of differentiation, owing to
decreased titin expression. The contractile apparatus cannot be assembled in its absence.154
In summary, downregulation of beta-catenin and Shh, BMP, and non-canonical Wnt
signaling are required to promote cardiomyocyte differentiation. Regulation of myofibrillar
gene expression is driven by SRF in concert with Nkx2.5 and GATA factors. SRF also
regulates expression of micro RNAs that promote cell cycle withdrawal. Hypoxia pathways
may also contribute to myocyte differentiation.
a. Chamber versus Non-chamber Myocardium—As morphogenesis of the heart
proceeds from the early phases of differentiation, the myocardium becomes subdivided into
either chamber (ventricles, atria) or non-chamber (outflow tract, AV canal, inner curvature,
central conduction system) myocardium.155 Non-chamber myocardium, similar to early-
differentiated cardiomyocytes, is relatively non-proliferative, whereas chamber myocardium
undergoes a “ballooning” phase of growth, beginning at about E9.5 that is driven by signals
from both endocardium and epicardium.
Delineation of chamber and non-chamber myocardium is achieved in part by expression of a
T-box transcription factor code, including Tbx2, Tbx3, Tbx20, Tbx5, and Tbx18 which
imparts regional myocyte identity and coordinately regulates regionally appropriate levels of
proliferation.156 T-box genes confer regional myocyte identity both by activating expression
of identity-appropriate genes, and by repressing expression of identity-inappropriate genes.
Localized expression of Tbx2 confers AV canal identity to the region separating the
ventricle from the atrium, repressing expression of chamber specific genes ANF (Nppa),
chisel, connexin 40 (Cx40), and connexin 43 (Cx43), and repressing proliferation.155 Tbx2
represses regulatory fragments of Cx40, Cx43, and Nppa, interacting with Nkx2.5 to repress
expression of the latter.157 Ectopic expression of Tbx2 in chamber myocardium results in
repression of chamber specific genes.155 Tbx2 is also required for development of the
outflow tract.158
Although active expression of Tbx2 within the heart is restricted to the AV canal and
outflow tract, recent genetic lineage tracing with a Tbx2Cre has revealed that Tbx2 lineages
make an unexpectedly large contribution to Tbx2-negative ventricles, with the embryonic
left ventricle only forming the left part of the definitive ventricular septum and the apex.159
Tbx2 lineages also contribute to the AV node, but not the AV bundle. In the outflow tract,
Tbx2 lineages formed the right ventricle and right part of the ventricular septum.
Tbx3 is co-expressed with Tbx2 in outflow tract progenitors and AV canal, and is
selectively expressed in the central conduction system. Tbx3 is required for normal
alignment of the outflow tract and normal ventricular septation.160 Tbx3 is also required for
specification of the AV conduction system, at least in part by repressing expression of
chamber specific genes.161
Tbx20, which is expressed throughout the developing heart, is required for proliferation and
expression of chamber myocardial genes and represses expression of Tbx2 in ventricular
chamber myocardium.140, 142, 162 Tbx5, expressed in atria and left ventricle, is required to
maintain expression of Nppa and Cx40.163 Tbx18 is expressed in sinus venosus myocardium
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and in a subset of SA nodal cells and is required in both lineages for their normal
development.164
b. Patterning of the AV Canal—The non-chamber myocardium of the AV canal
performs several specialized functions during heart development, serving as a slow
conducting “sphincter” in the early heart tube, and later actively participating in signaling to
form cardiac cushions and partition the heart. Patterning of AV myocardium is also likely to
affect development of the central conduction system, the AV node and associated structures.
Many details of the molecular pathway that regulates specification of AV canal myocardium
have been worked out. Normal AV patterning requires myocardial BMP4 and BMP2.165, 166
BMP2 An important role of BMP4 may be to activate transcription of the forkhead
transcription factor Foxn4 as studies in zebrafish embryos have demonstrated that Foxn4
directly regulates expression of Tbx2 in the AV canal.167 BMP2 also signals directly to
cushion-forming endocardium to induce EMT at least in part by activating expression of
Tbx2.166, 168 This has been demonstrated genetically with mice that are compound
heterozygous null for Bmp2 and Bmp4 are embryonic lethal, exhibiting outflow tract
malalignment, and defective septation of atria, ventricles, and AV canal revealing novel
functions of BMP2 in concert with BMP4.169 Msx1 genes are not only a target of BMP2,
but both regulate and cooperate with Tbx2 to pattern AV myocardium and to effect AV
cushion formation.170 Msx1 and Msx2 can directly interact with Tbx2 and Tbx3 to suppress
Cx43 promoter activity.171
BMP2 expression in mouse, and BMP4 expression in zebrafish is restricted to the
developing AV canal and inner curvature (IC) at least in part through the activity of Notch2
and Hey proteins.172 For example, in mice, embryos mutant for Hey2 exhibit an expanded
AVC domain of BMP2 and zebrafish mutants in Hey2 (aka gridlock) show ectopic
expression of BMP4. Conversely, in developing chick heart, ectopic activation of Notch2
signaling, or misexpression of either Hey1 or Hey2, represses BMP2. Moreover, ectopic
expression of Tbx2 inhibits expression of Hey1 and Hey2. Likewise, mouse embryos
ectopically expressing Hey1 throughout the heart display poorly defined boundaries of the
AV canal and expression levels of AV myocardial markers BMP2 and Tbx2 are weak or
undetectable though in this case, independent of Notch2 signaling. 173 Taken together these
studies suggest that Tbx2 expression may sharpen the border of developing AV canal and IC
by restricting Hey gene expression and hence BMP2 and BMP4 to prospective chamber
regions.
Myocardial identity can also regulate regionally vy MicroRNAs. For example,
MicroRNA-138 is expressed in AV canal in zebrafish heart and plays a role in establishing
the AV canal myocardium.174 Disruption of miR-138 function leads to ventricular
expansion of gene expression normally restricted to the AV canal and disrupted ventricular
cardiomyocyte morphology and function.
In summary, data are consistent with a model in which Hey1 and Hey2 expression bordering
the AV canal restricts BMP2 to AV canal myocardium. BMP signaling in turn activates
expression of Tbx2, Msx1 and Msx2, which cooperate to regulate the AV myocardial
phenotype. How Foxn4 interacts with BMP signaling remains to be determined.
c. Cardiac Conduction System—The specialized cardiac conduction system is
comprised of central slow-conducting components, which include the SA node, AV node,
His bundle and bundle branches, and fast-conducting components, including internodal
tracts, and Purkinje fibers.175-177 A number of connexins are specifically expressed within
certain components of the cardiac conduction system, and confer fast or slow conducting
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properties.178-180 Cx45 and Cx30.2 are expressed within nodal tissues, and Cx40 within
specialized fast-conducting tissues, with some Cx40 expression within the AV node. High
conductance channels Cx43 and Cx40 are expressed within the working myocardium of the
atria and ventricles. Recently a number of transcription factors important for conduction
system formation have been described, including Nkx2.5, Shox2, Hop, Irx4/Irx5, Tbx2,
Tbx3, Tbx18, Tbx5, and Id2. Their role in conduction system formation has been recently
reviewed.181, 182
Viral lineage tracing studies in chick embryos showed that conduction cells are
progressively recruited from cardiomyogenic cells with recruitment to elements of the
central conduction system (e.g. the His bundle) preceding recruitment to the peripheral
components of the network (i.e. subendocardial and periarterial Purkinje fibres).183-185
Birth dating studies in rodents suggest an analogous recruitment process occurs.186
Factors secreted by endothelial cells appear to be important for recruitment of myocardial
cells into Purkinje fiber lineages, and, at least in zebrafish, for AV conduction system
formation. In chick embryos, endothelin secreted by coronary vascular cells and
endocardium can influence recruitment of myocardial cells into the Purkinje fiber lineage.
187 Intriguingly, stretch influences the processing and secretion of ET-1 and stretch/flow
activates the expression of endothelin converting enzyme-1 (ECE-1). This in turn regulates
recruitment of myocardial cells into the Purkinje fiber lineage.188 In mouse embryos,
neuregulin, which is secreted by endocardium, can recruit myocardial cells into the Purkinje
fiber lineages.189 Endocardial signals are also important for formation of the AV
conduction ring in zebrafish heart, and Neuregulin and Notch1b are required for formation
of this central conduction tissue.190
Although a number of transcription factors are known to pattern the conduction system, we
know relatively little about the signaling pathways required for conduction system
formation, or the manner in which these signaling pathways cross talk with the transcription
factors that are important for conduction system specification.
d. Chamber Regionalization/Specialization—As discussed above, patterning, in large
part by T-box genes, differentiates chamber myocardium from non-chamber myocardium.
However, within chamber myocardium, sub-regionalization is also important to confer atrial
or ventricular identity, or to discriminate between left and right atria or ventricles. A number
of early studies suggested that both selective transcriptional activation and repression are
important for conferring regional chamber identity. Early studies of myofibrillar protein
mRNA expression in developing mouse heart demonstrated that many myofibrillar protein
isoforms are first expressed throughout early differentiating myocardium and then become
selectively downregulated in either atrial or ventricular chambers, within a time frame
specific to each isoform.191, 192 Three myosin genes which become transcriptionally
restricted to the mouse atria between embryonic day E12.5 and birth are coordinately
downregulated in compact myocardium of the left ventricle before that of the right ventricle.
115 Other isoforms exhibit more restricted domain specific expression from the beginning,
including MLC2v in mouse, and ventricular myosin heavy chain in zebrafish.55, 192
Analysis of transgene expression patterns has also revealed regional transcriptional
regulation.193 A myosin light chain (MLC) 3F-nlacZ-2E transgene is expressed in
embryonic right atrium, AV canal, and left ventricle, whereas an MLC3F-nlacZ-9 transgene
is expressed in atria, ventricles and AV canal, but not in inflow and outflow tracts.194
In keeping with these observations, a number of transcription factors have been described
that regulate activation or repression of region-specific gene expression. Tbx5 plays an
important role in conferring atrial identity and establishing the boundary between left and
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right ventricles. Irx4 is a ventricle-specific transcription factor that confers ventricular
identity by activating ventricular specific gene expression, and by repressing atrial specific
gene expression.195, 196 The basic helix-loop-helix transcriptional repressor Hey2 is
expressed specifically in ventricular myocytes, and confers ventricular identity.197
Cardiomyocyte-specific ablation of Hey2 results in ectopic activation of atrial genes in
ventricular myocardium, with an associated impairment of cardiac contractility and a unique
distortion in morphology of the right ventricular chamber. Forced expression of Hey2 in
atrial cardiomyocytes is sufficient to repress atrial cardiac genes.
In the mouse, the basic helix-loop-helix transcription factor Hand2 is expressed in cardiac
precursors throughout the cardiac crescent and the linear heart tube, before becoming
restricted to the right ventricular chamber at the onset of looping morphogenesis. A Hand2
enhancer that directs lacZ expression in this pattern requires two conserved GATA factor
consensus sites for expression in right ventricle but since GATAs are expressed universally
by myocardial cells this does not explain why Hand2 expression is limited to the right
ventricle.198 Hand1 is selectively expressed in the left ventricle, and, as for Tbx5, the
boundary between Hand1 expressing and non-expressing myocardium may affect formation
of the ventricular septum.199 Hand1 and Hand2 are critical for ventricular chamber
expansion, as ablation of both transcription factors in heart severely reduces ventricular
tissue.200
Thus, regional chamber identity is regulated by transcription factors that both activate and
restrict gene expression to confer chamber identity. Epigenetic mechanisms are also likely to
be involved in maintaining patterning of the mammalian myocardium.201 Maintenance of
Mlc3f transgene expression is regulated by a cell-autonomous mechanism that is
independent of DNA methylation, trichostatin A-sensitive histone deacetylation, or
misexpression of transcription factors that are expressed in left or right ventricles of
embryonic heart. This recalcitrance to ectopic activation is suggestive of a “locked”
epigenetic configuration, similar to silencing mediated by polycomb in Drosophila.
f. Epicardium and Myocardial Lineages—As discussed briefly above, cells from the
proepicardium migrate onto the early looping heart to give rise to the epicardium. One of the
roles of the developing epicardium is to promote proliferation of underlying myocardium.
Lineage studies in avians demonstrated that epicardial cells undergo epithelial-mesenchymal
transformation and delaminate from the epicardium to enter the myocardium to give rise to
cells of the coronary vasculature and interstitial fibroblasts.202, 203 It is likely that each of
these cell types is involved in crosstalk with myocardial cells, and in fact embryonic cardiac
fibroblasts have recently been shown to promote myocardial proliferation.204 Myocardial
signaling is reciprocally important for development of coronary vessels, which arise in part
from epicardial lineages. Crosstalk between the epicardium and myocardium has recently
been reviewed in depth in an article in the same series, and will not be discussed further
here.205 Here, we will focus on recent studies that have suggested that epicardial lineages
have the potential to adopt cardiomyocyte cell fates.
Proepicardial progenitors are contiguous with progenitors that will give rise to sinus venosus
myocardium, and both sets of progenitors express the T-box transcription factor Tbx18.206,
207 Studies in chick embryos have suggested that the ability of Tbx18 progenitors in this
domain to adopt either cardiomyocyte or proepicardial fate is based upon differential BMP
or FGF signaling respectively.208-210 Proepicardial cells can adopt a cardiomyocyte cell fate
when BMP-Smad signaling is activated in the context of inhibition of FGF signaling via
mitogen-activated protein kinase kinase 1/2.
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Lineage studies in mouse embryos utilizing two distinct epicardial-Cre mouse lines, Tbx18-
Cre and Wt1-Cre, and fluorescent tracker dye labeling of epicardial cells in heart organ
explant cultures, have suggested that, in addition to cardiac fibroblasts and coronary
vascular support cells, epicardial lineages may contribute to a subset of cardiomyocyte
lineages.40 Clonal analysis of proepicardial progenitors demonstrated that single clones were
able to give rise to both smooth muscle cells and cardiomyocytes in vitro. In the same
culture conditions, however, adult epicardial cells were able to adopt smooth muscle, but not
cardiomyocyte cell fate.40 As Cre lineage studies are subject to uncertainties concerning
expression domains of the Cre-driver,41 the question as to whether epicardial lineages
contribute to myocardial lineages in mouse embryos awaits “bona fide” in vivo lineage
tracing studies. In this regard, Kispert and colleagues have recently shown at the Weinstein
meeting that Tbx18 is expressed in the left ventricle and ventricular septum as well as in the
epicardium, thus leaving open the question of an epicardium-derived cardiomyocyte lineage.
211
The foregoing suggests that proepicardial lineages have the capacity to be directed toward a
myocardial cell fate, at least in vitro, whereas later stage epicardial cells may have lost this
ability. Understanding genetic differences between proepicardial and adult epicardial cells
that are responsible for differences in ability to adopt cardiomyocyte cell fates may have
important implications for utilization of epicardial cells for cardiac repair.
g. Growth Signals from Endocardium—As with the epicardium, growth factor
signaling from endocardium to myocardium is responsible for stimulation of myocardial
proliferation following cardiac looping. The early ventricular myocardium is composed of
trabeculae, fingerlike projections of myocardium that are lined by endocardium, the
specialized vascular endothelium lining the heart. This structure provides for a high
endocardial cell to myocardial cell ratio.
Neuregulin 1 (NRG1) secreted by endocardial cells activates ErbB2 and ErbB4 receptors in
myocardial cells to promote formation of trabecular myocardium.212-214 Serotonin
signaling through 5-HT(2B) receptors is required for expression of ErbB2 in ventricular
myocardium, and mutants of 5-HT(2B) receptors exhibit impaired trabeculation.215 Notch
signaling within endocardium functions upstream of NRG1 with mutants for Notch 1 and
the transcriptional effector downstream of Notch, RbpJ, exhibiting impaired trabeculation,
and decreased myocardial proliferation.216 Thus, Notch signaling in endocardium is
required for expression of EphrinB2, which in turn activates expression of NRG1.
Endocardial Notch signaling also activates expression of BMP10 in myocardium, which is
required for trabecular proliferation. BMP10 null mice display ectopic and elevated
expression of p57(kip2) and a dramatic reduction in proliferative activity in cardiomyocytes
at E9.5. BMP10 is also required for maintaining normal expression levels of Nkx2.5 and
Mef2C in developing myocardium at mid-gestation.217 Myocardial specific ablation of
Nkx2.5 results in increased expression of BMP10, resulting in over-proliferation of
trabeculae,218 suggesting a negative feedback loop from BMP10 to Nkx2.5 which is
required for regulation of normal trabecular growth. It is interesting that this echoes an
earlier BMP-Nkx2.5 feedback loop required during early cardiac specification.84
FGF signaling from either epicardium or endocardium stimulates myocardial proliferation.
FGF9, FGF16, and FGF20 are expressed in endocardium as well as epicardium, and
endocardially-derived FGF signals regulate myocardial proliferation during midgestation
heart development.219 Ablation of FGF16 results in embryonic lethality with poor
trabeculation and thin-walled myocardium.220
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Modulation of extracellular matrix by proteases secreted by endocardium can also modulate
myocardial growth. For example, ADAMTS1 is a metalloprotease normally expressed in the
matrix assocaited with the endocardium at later stages of trabecular development, when
trabecular growth is slowing221. Ablation of the chromatin remodeling protein Brg1 results
in precocious expression of ADAMTS1 and thus, inhibits early trabecular growth.
In summary, Notch signaling within endocardium activates mid-gestation myocardial
growth through two pathways. Endocardial Notch signaling upregulates EphrinB2 required
to upregulate endocardial Neuregulin, which binds to myocardial ErbB2/ErbB4 receptors to
stimulate growth. Notch signaling within endocardium also upregulates BMP10 in
myocardium, through as yet unknown mediators. Serotonin, FGF, and protease pathways are
also critical to the crosstalk between endocardium and myocardium at mid-gestation to
regulate proliferation of myocardium. Although FGF and BMP signaling are also important
for proliferation of cardiac progenitors prior to differentiation, ErbB2/ErbB4 signaling
appears to be specific for proliferation of differentiated cardiomyocytes. It will be of future
interest to investigate commonalities and differences between endocardial and epicardial
pathways which crosstalk to cardiomyocytes. It is interesting to speculate that differential
stimulation of pathways from either source may influence endocardial to epicardial gradients
of gene expression.
Summary
The journey of a prospective myocardial epiblast cell to a highly specialized cardiomyocyte
is a “long and winding road”. Proximity to signals emanating from the node (retinoic acid,
nodal) may impart initial craniocaudal and left-right axis information to the presumptive
cardiomyocyte, which will be reinforced later by signals from lateral plate mesoderm and
genetic pathways within cardiogenic progenitors and cardiomyocytes themselves. Axial
patterning programs are likely to drive individual cell migratory and proliferative behavior.
Reliance on and proximity to endodermal signals during development is another theme for
presumptive cardiomyocytes, including early position in the epiblast, during initial
ingression at gastrulation, and later when the cardiac crescent forms adjacent to definitive
anterior endoderm. As cardiogenic progenitors enter the heart to become myocytes, they are
in proximity to other cardiac cell types, including endocardial and epicardial lineages, which
are also involved in signaling and crosstalk to influence myocardial development.
Becoming a specialized cardiomyocyte is a complex ordered process involving
specification, differentiation and specialization. This process involves an ordered activation
and repression of growth factor signaling pathways, regulated by transcription factor
regulation of ligands, receptors, transcription factors, and microRNAs. Activation of a
particular pathway has several outcomes, the most immediate goal of stimulating
proliferation, cell motility/polarity, differentiation, or further specialization, and at the same
time the initiation of the next phase in the cascade, which in turn downregulates activation
of the initial pathway, ensuring progression. During and after chamber formation, signaling
to establish and maintain specialization and proliferation of the myocardium to form
trabeculae and other specializations falls to the endocardium and epicardium. Maintenance
of the specialized state is also likely to require active signaling processes.
Much of our work to date has focused on earliest stages of heart development, while less is
known as to signaling pathways required for maturation of cardiomyocytes from late fetal
stages onward. Understanding the complexities of building cardiac tissue from these stages
will be of great future interest and will inform research aimed at cardiac tissue engineering.
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Non-standard Abbreviations and Acronyms
E Embryonic day
HH Hamburger-Hamilton staging procedure for chick
AV atrioventricular
MLC myosin light chain
MHC myosin heavy chain
Isl1 islet 1
Tbx T-box transcription factor
Flk fetal liver kinase 1
Nkx NK homeodomain factor
FGF fibroblast growth factor
aMHC atrial myosin heavy chain
vMHC ventricular myosin heavy chain
Mesp1 mesoderm posterior 1 homolog
Cre cyclization recombination
Fgfr fibroblast growth factor receptor
BMP bone morphogenetic protein
Smad drosophila protein mothers against decapentaplegic (MAD) and C. elegans
protein SMA
Oep one-eyed pinhead
Wnt Wg (wingless) and Int
LIM LIN-11, Islet-1, and MEC-3
Shh Sonic hedgehog
RALDH retinoic acid dehydrogenase
Hox homeobox gene
DiI 1,1′-dioctadecyl-3,3,3′3′-tetramethylindocarbocyanine perchlorate
TGF transforming growth factor
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RhoA Ras homolog gene family, member A
ROCK Rho-associated, coiled-coil containing protein kinase
Gli glioblastoma
ERT estrogen replacement therapy
Crkl Crk-like protein
ALK activin like kinase
Hod homeodomain-only protein
Mef myocyte enhancer factor
SRF serum response factor
MADS mothers against decapentaplegic
miR microRNA
HIF hypoxia inducible factor
RNA ribonucleic acid
DNA deoxynucleic acid
ANF atrial natriuretic factor








Shox Short stature homeobox gene
Irx Iroquois
ET endothelin
ECE endothelin converting enzyme
ErbB erythroblastic leukemia viral oncogene homolog
5HT 5-hydroxytryptamine
ADAMTS a disintegrin and metalloproteinase with a thrombospondin type 1 motif
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Schematic representation of heart tube formation in mouse (a, b, c) and chick (d, e, f). First
heart progenitors are shown in blue and second heart progenitors in red. (a,d) Fate mapping
studies have defined the locations of chick and mouse cardiac progenitors in the heart fields.
(a) Lateral view of an E6.5 mouse embryo. (d) Dorsal view of an HH5 chick embryo. (b,e)
Fusion and differentiation of the heart fields is more rapid in the mouse leading to a cardiac
crescent that is not seen in the chick. Second heart progenitors are located medially in both
chick and mouse heart fields but quickly change positions to cranial as the heart fields
converge on the midline. (b) Ventral view of an E8.5 mouse embryo showing the cardiac
crescent and its relationship with the anterior intestinal portal (curved black line). (e) Ventral
view of an HH8 chick embryo showing convergence of the heart fields in the ventral midline
and how the first and second heart field progenitors have rotated their position from medial-
lateral to craniocaudal. (c,f) Second heart progenitors are gradually added to the elongating
cardiac tube. (c) Ventral view of an E9.5 mouse embryo. (f) Ventral view of an HH12 chick
embryo. The caudal second heart progenitors are shifted by formation of the foregut pocket
and anterior intestinal portal (curved black line) to cranial, thus putting them in place to
contribute to the outflow pole. Some of the second heart field progenitors are also added to
the venous pole: parts of the atrium and atrial septum but these are incorporated later than
the stages shown, hence no red cells are seen at these stages in the venous pole. The
proximal and distal outflow myocardium is added over an extended period of time (reprinted
from 222 with permission).
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Schematic representation of key stages in heart tube formation in frog (a, b, c) and fish (d, e,
f). (a, d) Fate mapping studies have defined the locations of frog and fish cardiac progenitors
prior to gastrulation. (a) Lateral view of a 32-cell stage Xenopus embryo, dorsal to the right,
indicating the blastomeres (red) that will give rise to descendants in the adult heart. (d)
Lateral view of a zebrafish embryo at the 40% epiboly stage, dorsal to the right, indicating
the approximate locations of the blastomeres (red) that will give rise to the myocardium. (b,
e) Fate maps and the expression patterns of molecular markers have demonstrated the
locations of the bilateral heart fields in both frog and fish. (b) Anterior-ventral view of a
Xenopus mid-tadpole, anterior to the top, just prior to the fusion of the heart fields (red) at
the ventral midline. Cement gland is labeled in black and eyes are labeled in grey. Note: In
Xenopus, unlike zebrafish, the atrial and ventricular precursor populations are not distinct
populations but rather the precursors are intermingled until very late in heart development.
(e) Dorsal view of a zebrafish embryo at the 7-somite stage, anterior to the top, indicating
the locations of ventricular myocardial progenitors (red) and atrial myocardial progenitors
(blue) prior to cardiac fusion. Notochord is labeled in black and eyes are labeled in grey. (c.
f) Expression patterns of molecular markers have indicated the existence of discrete
myocardial subpopulations as the heart tube forms. (c) Lateral view of a Xenopus tadpole at
stage 25, anterior to the left, after fusion of the cardiac progenitors at the midline. Molecular
markers distinguish cardiac populations expressing Tbx1 and Isl-1 (lavender) from those that
do not (green). (f) Dorsal view of a zebrafish embryo at the 21-somite stage, anterior to the
top, indicating the locations of ventricular cardiomyocytes (red) and atrial cardiomyocytes
(blue) within the cardiac cone.
Evans et al. Page 33
























































































































































































































































Circ Res. Author manuscript; available in PMC 2011 December 10.
